Of note, high CysLT1 expression is associated with poor prognosis and reduced survival in both colorectal [28] and breast cancer [29], while CysLT2 has been reported to have an anti-tumorigenic effect in colorectal cancer [52]. The gene discussed is CYSLTR1; the disease is breast carcinoma.